世界の抗炎症生物製剤市場:成長動向・競争分析2020-2026

【英語タイトル】Global Anti-inflammatory Biologics Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00113)・商品コード:QYR20AP00113
・発行会社(調査会社):QYResearch
・発行日:2020年3月23日(※2024年版があります。お問い合わせください)
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、抗炎症生物製剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、抗炎症生物製剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(合成タイプ、生物タイプ)、用途別市場規模(関節炎、呼吸器疾患、皮膚科、消化器科、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・抗炎症生物製剤の種類別市場2015-2026:合成タイプ、生物タイプ
・抗炎症生物製剤の用途別市場2015-2026:関節炎、呼吸器疾患、皮膚科、消化器科、その他
・抗炎症生物製剤の北米市場分析
・抗炎症生物製剤のアジア市場分析
・抗炎症生物製剤の中南米市場分析
・抗炎症生物製剤の中東・アフリカ市場分析
・関連企業情報:AbbVie、Johnson & Johnson、Amgen Inc、AstraZeneca PLC、Pfizer, Inc、Novartis、Roche、Sun Pharmaceutical Industries Ltd、Sanofi、GlaxoSmithKline
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

The biologics used in Anti-inflammatory treatment – abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), etanercept (Enbrel), infliximab (Remicade) and rituximab (Rituxan) – block triggers of inflammation. Biologics may be used alone or in combination with a traditional DMARD to treat autoimmune forms of arthritis, such as RA juvenile idiopathic arthritis (JIA), ankylosing spondylitis or psoriasis/psoriatic arthritis. Biologics are given as an injection or infusion, and as such, there is always a risk of an injection site reaction or an infusion reaction.In 2019, the global Anti-inflammatory Biologics market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti-inflammatory Biologics.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti-inflammatory Biologics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti-inflammatory Biologics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti-inflammatory Biologics market. Readers of the report can become informed about current and future trends of the global Anti-inflammatory Biologics market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti-inflammatory Biologics markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti-inflammatory Biologics market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti-inflammatory Biologics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti-inflammatory Biologics market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti-inflammatory Biologics market is segmented into
Synthetic Type
Biological Type

Market Segment by Application, the Anti-inflammatory Biologics market is segmented into
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

This report includes the following manufacturers; we can also add the other companies as you want.
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline

The study objectives are:
To analyze and research the global Anti-inflammatory Biologics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti-inflammatory Biologics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-inflammatory Biologics are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti-inflammatory Biologics Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti-inflammatory Biologics Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Synthetic Type
1.3.3 Biological Type
1.4 Market Segment by Application
1.4.1 Global Anti-inflammatory Biologics Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Arthritis
1.4.3 Respiratory Diseases
1.4.4 Dermatology
1.4.5 Gastroenterology
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti-inflammatory Biologics Revenue (2015-2026)
2.1.1 Global Anti-inflammatory Biologics Revenue (2015-2026)
2.1.2 Global Anti-inflammatory Biologics Sales (2015-2026)
2.2 Anti-inflammatory Biologics Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti-inflammatory Biologics Sales by Regions (2015-2020)
2.2.2 Global Anti-inflammatory Biologics Revenue by Regions (2015-2020)
2.3 Global Top Anti-inflammatory Biologics Regions (Countries) Ranking by Market Size
2.4 Anti-inflammatory Biologics Industry Trends
2.4.1 Anti-inflammatory Biologics Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti-inflammatory Biologics Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti-inflammatory Biologics Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-inflammatory Biologics Manufacturers by Sales (2015-2020)
3.1.1 Global Anti-inflammatory Biologics Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-inflammatory Biologics Sales in 2019
3.2 Global Top Manufacturers Anti-inflammatory Biologics by Revenue
3.2.1 Global Anti-inflammatory Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-inflammatory Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-inflammatory Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2019)
3.4 Global Anti-inflammatory Biologics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-inflammatory Biologics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-inflammatory Biologics Market
3.7 Key Manufacturers Anti-inflammatory Biologics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti-inflammatory Biologics Historic Market Review by Type (2015-2020)
4.1.2 Global Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
4.1.3 Global Anti-inflammatory Biologics Revenue Market Share by Type (2015-2020)
4.1.4 Anti-inflammatory Biologics Price by Type (2015-2020)
4.1 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti-inflammatory Biologics Sales Forecast by Type (2021-2026)
4.2.3 Global Anti-inflammatory Biologics Revenue Forecast by Type (2021-2026)
4.2.4 Anti-inflammatory Biologics Price Forecast by Type (2021-2026)

5 Global Anti-inflammatory Biologics Market Size by Application
5.1 Global Anti-inflammatory Biologics Historic Market Review by Application (2015-2020)
5.1.2 Global Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
5.1.3 Global Anti-inflammatory Biologics Revenue Market Share by Application (2015-2020)
5.1.4 Anti-inflammatory Biologics Price by Application (2015-2020)
5.2 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti-inflammatory Biologics Sales Forecast by Application (2021-2026)
5.2.3 Global Anti-inflammatory Biologics Revenue Forecast by Application (2021-2026)
5.2.4 Anti-inflammatory Biologics Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-inflammatory Biologics Breakdown Data by Company
6.2 North America Anti-inflammatory Biologics Breakdown Data by Type
6.3 North America Anti-inflammatory Biologics Breakdown Data by Application
6.4 North America Anti-inflammatory Biologics Breakdown Data by Countries
6.4.1 North America Anti-inflammatory Biologics Sales by Countries
6.4.2 North America Anti-inflammatory Biologics Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti-inflammatory Biologics Breakdown Data by Company
7.2 Europe Anti-inflammatory Biologics Breakdown Data by Type
7.3 Europe Anti-inflammatory Biologics Breakdown Data by Application
7.4 Europe Anti-inflammatory Biologics Breakdown Data by Countries
7.4.1 Europe Anti-inflammatory Biologics Sales by Countries
7.4.2 Europe Anti-inflammatory Biologics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Biologics Breakdown Data by Company
8.2 Asia Pacific Anti-inflammatory Biologics Breakdown Data by Type
8.3 Asia Pacific Anti-inflammatory Biologics Breakdown Data by Application
8.4 Asia Pacific Anti-inflammatory Biologics Breakdown Data by Regions
8.4.1 Asia Pacific Anti-inflammatory Biologics Sales by Regions
8.4.2 Asia Pacific Anti-inflammatory Biologics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti-inflammatory Biologics Breakdown Data by Company
9.2 Latin America Anti-inflammatory Biologics Breakdown Data by Type
9.3 Latin America Anti-inflammatory Biologics Breakdown Data by Application
9.4 Latin America Anti-inflammatory Biologics Breakdown Data by Countries
9.4.1 Latin America Anti-inflammatory Biologics Sales by Countries
9.4.2 Latin America Anti-inflammatory Biologics Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti-inflammatory Biologics Breakdown Data by Type
10.2 Middle East and Africa Anti-inflammatory Biologics Breakdown Data by Application
10.3 Middle East and Africa Anti-inflammatory Biologics Breakdown Data by Countries
10.3.1 Middle East and Africa Anti-inflammatory Biologics Sales by Countries
10.3.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AbbVie Anti-inflammatory Biologics Products and Services
11.1.5 AbbVie SWOT Analysis
11.1.6 AbbVie Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Anti-inflammatory Biologics Products and Services
11.2.5 Johnson & Johnson SWOT Analysis
11.2.6 Johnson & Johnson Recent Developments
11.3 Amgen Inc
11.3.1 Amgen Inc Corporation Information
11.3.2 Amgen Inc Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Amgen Inc Anti-inflammatory Biologics Products and Services
11.3.5 Amgen Inc SWOT Analysis
11.3.6 Amgen Inc Recent Developments
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Corporation Information
11.4.2 AstraZeneca PLC Business Overview and Total Revenue (2019 VS 2018)
11.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products and Services
11.4.5 AstraZeneca PLC SWOT Analysis
11.4.6 AstraZeneca PLC Recent Developments
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Corporation Information
11.5.2 Pfizer, Inc Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Pfizer, Inc Anti-inflammatory Biologics Products and Services
11.5.5 Pfizer, Inc SWOT Analysis
11.5.6 Pfizer, Inc Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Novartis Anti-inflammatory Biologics Products and Services
11.6.5 Novartis SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Roche Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Roche Anti-inflammatory Biologics Products and Services
11.7.5 Roche SWOT Analysis
11.7.6 Roche Recent Developments
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products and Services
11.8.5 Sun Pharmaceutical Industries Ltd SWOT Analysis
11.8.6 Sun Pharmaceutical Industries Ltd Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Sanofi Anti-inflammatory Biologics Products and Services
11.9.5 Sanofi SWOT Analysis
11.9.6 Sanofi Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products and Services
11.10.5 GlaxoSmithKline SWOT Analysis
11.10.6 GlaxoSmithKline Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti-inflammatory Biologics Sales Channels
12.2.2 Anti-inflammatory Biologics Distributors
12.3 Anti-inflammatory Biologics Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.1.1 Global Anti-inflammatory Biologics Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti-inflammatory Biologics Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.2.2 North America Anti-inflammatory Biologics Revenue Forecast (2021-2026)
13.2.3 North America Anti-inflammatory Biologics Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.3.2 Europe Anti-inflammatory Biologics Revenue Forecast (2021-2026)
13.3.3 Europe Anti-inflammatory Biologics Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti-inflammatory Biologics Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti-inflammatory Biologics Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.5.2 Latin America Anti-inflammatory Biologics Revenue Forecast (2021-2026)
13.5.3 Latin America Anti-inflammatory Biologics Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti-inflammatory Biologics Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti-inflammatory Biologics Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti-inflammatory Biologics Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Anti-inflammatory Biologics Key Market Segments
Table 2. Ranking of Global Top Anti-inflammatory Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-inflammatory Biologics Market Size Growth Rate by Type 2021-2026 (K MT) & (Million US$)
Table 4. Major Manufacturers of Synthetic Type
Table 5. Major Manufacturers of Biological Type
Table 6. Global Anti-inflammatory Biologics Market Share by Application 2019-2025 (K MT)
Table 7. Global Anti-inflammatory Biologics Market Size by Regions 2015-2020 (K MT) & (Million US$)
Table 8. Global Anti-inflammatory Biologics Sales by Regions 2015-2020 (K MT)
Table 9. Global Anti-inflammatory Biologics Sales Market Share by Regions 2015-2020
Table 10. Global Anti-inflammatory Biologics Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Anti-inflammatory Biologics Revenue Market Share by Regions 2015-2020
Table 12. Top Anti-inflammatory Biologics Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Anti-inflammatory Biologics Key Drivers: Impact Analysis (2021-2026)
Table 15. Anti-inflammatory Biologics Key Challenges
Table 16. Main Points Interviewed from Key Anti-inflammatory Biologics Players: Views for Future
Table 17. Global Anti-inflammatory Biologics Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Anti-inflammatory Biologics Sales Share by Manufacturers (2015-2020)
Table 19. Anti-inflammatory Biologics Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Anti-inflammatory Biologics Revenue Share by Manufacturers (2015-2020)
Table 21. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Biologics as of 2019)
Table 23. Key Manufacturers Anti-inflammatory Biologics Average Selling Price (ASP) (2015-2020) (USD/MT)
Table 24. Key Manufacturers Anti-inflammatory Biologics Plants/Factories Distribution
Table 25. Key Manufacturers Anti-inflammatory Biologics Area Served
Table 26. Date of Key Manufacturers Enter into Anti-inflammatory Biologics Market
Table 27. Key Manufacturers Anti-inflammatory Biologics Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Synthetic Type Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 30. Global Biological Type Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 31. Global Anti-inflammatory Biologics Sales (K MT) by Type (2015-2020)
Table 32. Global Anti-inflammatory Biologics Sales Share by Type (2015-2020)
Table 33. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Anti-inflammatory Biologics Price (K MT) by Type (2015-2020)
Table 35. Global Anti-inflammatory Biologics Sales (K MT) by Type (2021-2026)
Table 36. Global Anti-inflammatory Biologics Sales Share by Type (2021-2026)
Table 37. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Anti-inflammatory Biologics Revenue Share by Type (2021-2026)
Table 39. Global Anti-inflammatory Biologics Price (K MT) by Type (2021-2026)
Table 40. Global Anti-inflammatory Biologics Sales (K MT) by Application (2015-2020)
Table 41. Global Anti-inflammatory Biologics Sales Share by Application (2015-2020)
Table 42. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Anti-inflammatory Biologics Price by Application 2015-2020 (USD/MT)
Table 44. Global Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 45. Global Anti-inflammatory Biologics Sales Share by Application (2015-2020)
Table 46. Global Anti-inflammatory Biologics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Anti-inflammatory Biologics Revenue Share by Application (2021-2026)
Table 48. Global Anti-inflammatory Biologics Price (K MT) by Application (2021-2026)
Table 49. North America Anti-inflammatory Biologics Sales by Company (2015-2020) (K MT)
Table 50. North America Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 51. North America Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 52. North America Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 53. North America Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 54. North America Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 55. North America Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 56. North America Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 57. North America Anti-inflammatory Biologics Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Anti-inflammatory Biologics Sales by Company (2015-2020) (K MT)
Table 60. Europe Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 61. Europe Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 62. Europe Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 63. Europe Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 64. Europe Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 65. Europe Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 66. Europe Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 67. Europe Anti-inflammatory Biologics Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Anti-inflammatory Biologics Sales by Regions (2015-2020) (K MT)
Table 70. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 72. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 74. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 76. Asia Pacific Anti-inflammatory Biologics Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Anti-inflammatory Biologics Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Anti-inflammatory Biologics Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Anti-inflammatory Biologics Sales by Company (2015-2020) (K MT)
Table 80. Latin America Anti-inflammatory Biologics Sales Market Share by Company (2015-2020)
Table 81. Latin America Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 82. Latin America Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 83. Latin America Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 84. Latin America Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 85. Latin America Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 86. Latin America Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 87. Latin America Anti-inflammatory Biologics Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 90. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 92. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 94. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Anti-inflammatory Biologics Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 97. AbbVie Company Details
Table 98. AbbVie Description and Business Overview
Table 99. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. AbbVie Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 101. AbbVie Anti-inflammatory Biologics Sales Market Share in Global Market
Table 102. AbbVie Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 107. Johnson & Johnson Anti-inflammatory Biologics Sales Market Share in Global Market
Table 108. Johnson & Johnson Recent Development
Table 109. Amgen Inc Company Details
Table 110. Amgen Inc Description and Business Overview
Table 111. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Amgen Inc Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 113. Amgen Inc Anti-inflammatory Biologics Sales Market Share in Global Market
Table 114. Amgen Inc Recent Development
Table 115. AstraZeneca PLC Company Details
Table 116. AstraZeneca PLC Description and Business Overview
Table 117. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. AstraZeneca PLC Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 119. AstraZeneca PLC Anti-inflammatory Biologics Sales Market Share in Global Market
Table 120. AstraZeneca PLC Recent Development
Table 121. Pfizer, Inc Company Details
Table 122. Pfizer, Inc Description and Business Overview
Table 123. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Pfizer, Inc Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 125. Pfizer, Inc Anti-inflammatory Biologics Sales Market Share in Global Market
Table 126. Pfizer, Inc Recent Development
Table 127. Novartis Company Details
Table 128. Novartis Description and Business Overview
Table 129. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Novartis Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 131. Novartis Anti-inflammatory Biologics Sales Market Share in Global Market
Table 132. Novartis Recent Development
Table 133. Roche Company Details
Table 134. Roche Description and Business Overview
Table 135. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Roche Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 137. Roche Anti-inflammatory Biologics Sales Market Share in Global Market
Table 138. Roche Recent Development
Table 139. Sun Pharmaceutical Industries Ltd Company Details
Table 140. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 141. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 143. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales Market Share in Global Market
Table 144. Sun Pharmaceutical Industries Ltd Recent Development
Table 145. Sanofi Company Details
Table 146. Sanofi Description and Business Overview
Table 147. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Sanofi Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 149. Sanofi Anti-inflammatory Biologics Sales Market Share in Global Market
Table 150. Sanofi Recent Development
Table 151. GlaxoSmithKline Company Details
Table 152. GlaxoSmithKline Description and Business Overview
Table 153. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. GlaxoSmithKline Anti-inflammatory Biologics Sales Growth Rate (2015-2020)
Table 155. GlaxoSmithKline Anti-inflammatory Biologics Sales Market Share in Global Market
Table 156. GlaxoSmithKline Recent Development
Table 157. Anti-inflammatory Biologics Distributors List
Table 158. Anti-inflammatory Biologics Customers List
Table 159. Global Anti-inflammatory Biologics Sales Forecast 2021-2026 (K MT) & (Million US$)
Table 160. Global Anti-inflammatory Biologics Sales Forecast by Type 2021-2026 (K MT)
Table 161. Global Anti-inflammatory Biologics Sales Forecast by Application 2021-2026 (K MT)
Table 162. Global Anti-inflammatory Biologics Sales Forecast by Regions 2021-2026 (K MT)
Table 163. Global Anti-inflammatory Biologics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 164. North America Anti-inflammatory Biologics Sales Forecast by Countries 2021-2026 (K MT)
Table 165. North America Anti-inflammatory Biologics Revenue Forecast by Countries 2021-2026
Table 166. Europe Anti-inflammatory Biologics Sales Forecast by Countries 2021-2026 (K MT)
Table 167. Europe Anti-inflammatory Biologics Revenue Market Share Forecast by Countries 2021-2026
Table 168. Asia Pacific Anti-inflammatory Biologics Sales Forecast by Regions 2021-2026 (K MT)
Table 169. Asia Pacific Anti-inflammatory Biologics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 170. Latin America Anti-inflammatory Biologics Sales Forecast by Countries 2021-2026 (K MT)
Table 171. Latin America Anti-inflammatory Biologics Revenue Forecast by Countries 2021-2026 (Million US$)
Table 172. Middle East and Africa Anti-inflammatory Biologics Sales Forecast by Regions 2021-2026 (K MT)
Table 173. Middle East and Africa Anti-inflammatory Biologics Revenue Forecast by Regions 2021-2026 (Million US$)
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Biologics Product Picture
Figure 2. Global Anti-inflammatory Biologics Sales Market Shar by Type 2015-2026
Figure 3. Synthetic Type Figures
Figure 4. Biological Type Figures
Figure 5. Global Anti-inflammatory Biologics Sales Market Share by Application in 2019 & 2026
Figure 6. Arthritis Use Case
Figure 7. Respiratory Diseases Use Case
Figure 8. Dermatology Use Case
Figure 9. Gastroenterology Use Case
Figure 10. Others Use Case
Figure 11. Anti-inflammatory Biologics Report Years Considered
Figure 12. Global Anti-inflammatory Biologics Market Size 2015-2026 (Million US$)
Figure 13. Global Anti-inflammatory Biologics Sales 2015-2020 (K MT)
Figure 14. Global Anti-inflammatory Biologics Market Size Market Share by Regions 2015-2020
Figure 15. Global Anti-inflammatory Biologics Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Anti-inflammatory Biologics Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-inflammatory Biologics Sales in 2019
Figure 19. Anti-inflammatory Biologics Value Share by Manufacturers in 2019
Figure 20. Anti-inflammatory Biologics Revenue Share by Manufacturers In 2019
Figure 21. Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Anti-inflammatory Biologics Revenue Share by Type (2015-2020)
Figure 23. Global Anti-inflammatory Biologics Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Anti-inflammatory Biologics Market Share by Price Range (2015-2020)
Figure 25. Global Anti-inflammatory Biologics Revenue Share by Application (2015-2020)
Figure 26. Global Anti-inflammatory Biologics Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Anti-inflammatory Biologics Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 29. Canada Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 30. Europe Anti-inflammatory Biologics Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 32. France Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.K. Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 34. Italy Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 35. Russia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 36. Asia Pacific Anti-inflammatory Biologics Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 38. Japan Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 39. South Korea Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 40. India Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 41. Australia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 42. Taiwan Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 43. Indonesia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 44. Thailand Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 45. Malaysia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 46. Philippines Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 47. Vietnam Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 48. Latin America Anti-inflammatory Biologics Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 50. Brazil Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 51. Argentina Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Middle East and Africa Anti-inflammatory Biologics Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 54. Saudi Arabia Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.A.E Anti-inflammatory Biologics Sales Growth Rate (2015-2020) (K MT)
Figure 56. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sun Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Anti-inflammatory Biologics Value Chain
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. North America Anti-inflammatory Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 70. North America Anti-inflammatory Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Europe Anti-inflammatory Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 72. Europe Anti-inflammatory Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Asia Pacific Anti-inflammatory Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 74. Asia Pacific Anti-inflammatory Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Latin America Anti-inflammatory Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 76. Latin America Anti-inflammatory Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Middle East and Africa Anti-inflammatory Biologics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 78. Middle East and Africa Anti-inflammatory Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed


【掲載企業】

AbbVie、Johnson & Johnson、Amgen Inc、AstraZeneca PLC、Pfizer, Inc、Novartis、Roche、Sun Pharmaceutical Industries Ltd、Sanofi、GlaxoSmithKline

★調査レポート[世界の抗炎症生物製剤市場:成長動向・競争分析2020-2026] (コード:QYR20AP00113)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗炎症生物製剤市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆